Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Drug Targets. Inflammation and Allergy|December 9, 2004
Primary lung lymphomaDaniele Vallisa, Elena Trabacchi, Luigi Cavanna
Diagnostic and Interventional Radiology (Ankara, Turkey)|November 13, 2012
Inversion time prolongation at late enhancement cardiac MRI in a myeloma patientElena Belloni, Giuseppe Marchesi, Daniela Aschieri, et al.
Haematologica|February 17, 2005
Primary pancreatic lymphoma. Report of five casesAnnalisa Arcari, Elisa Anselmi, Patrizia Bernuzzi, et al.
Haematologica|March 26, 2003
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemiaGianantonio Rosti, Elena Trabacchi, Simona Bassi, et al.
Haematologica|June 4, 2008
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumorRita Santachiara, Rossana Maffei, Silvia Martinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experienceDaniele Vallisa, Patrizia Bernuzzi, Luca Arcaini, et al.
Blood Transfusion = Trasfusione Del Sangue|March 12, 2015
Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimensSimona Bassi, Elisa M Stroppa, Carlo F Moroni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid LeukemiaSimona Soverini, Giovanni Martinelli, Gianantonio Rosti, et al.
Blood|December 3, 2003
Molecular response to imatinib in late chronic-phase chronic myeloid leukemiaGianantonio Rosti, Giovanni Martinelli, Simona Bassi, et al.
Targeted Oncology|October 18, 2021
Making Treatment-Free Remission (TFR) Easier in Chronic Myeloid Leukemia: Fact-Checking and Practical Management ToolsFausto Castagnetti, Gianni Binotto, Isabella Capodanno, et al.
Pageof 2